Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porcel, J. M.
Right arrow Articles by Esquerda, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porcel, J. M.
Right arrow Articles by Esquerda, A.
(Chest. 2004;125:160-164.)
© 2004 American College of Chest Physicians

Tumor Necrosis Factor-{alpha} in Pleural Fluid*

A Marker of Complicated Parapneumonic Effusions

José Manuel Porcel, MD, FCCP; Manuel Vives, MD and Aureli Esquerda, PharmD

* From the Departments of Internal Medicine (Dr. Porcel) and Clinical Laboratory (Dr. Esquerda), University Hospital Arnau de Vilanova, Lleida; and Division of Internal Medicine (Dr. Vives), Clínica Recoletas, Albacete, Spain.

Correspondence to: José Manuel Porcel, MD, FCCP, Department of Internal Medicine, University Hospital Arnau de Vilanova, Alcalde Rovira Roure 80, 25198 Lleida, Spain; e-mail: jporcelp{at}medynet.com

Study objectives: We sought to determine whether pleural fluid tumor necrosis factor (TNF)-{alpha} is a more accurate parameter to identify nonpurulent complicated parapneumonic effusion (CPPE) than the classical chemistries, namely pH, glucose, or lactate dehydrogenase (LDH).

Methods: We studied 80 consecutive patients with parapneumonic effusions (35 with uncomplicated parapneumonic effusion [UPPE], 23 with nonpurulent CPPE, and 22 with empyema). Concentrations of standard biochemical parameters together with TNF-{alpha} were measured in pleural fluid, the latter by using an immunoenzymometric assay.

Results: Pleural TNF-{alpha} was significantly higher in CPPE (133.0 pg/mL) and empyema (142.2 pg/mL) than in UPPE (39.1 pg/mL). A cut-off value of 80 pg/mL for pleural TNF-{alpha} resulted in a sensitivity, specificity, and area under receiver operating characteristic curve (AUC) of 78%, 89%, and 0.87, respectively, for the diagnosis of nonpurulent CPPE. A multivariate analysis selected both pleural TNF-{alpha} >= 80 pg/mL and LDH >= 1,000 U/L (sensitivity, 74%; AUC = 0.86), but excluded pleural glucose <= 60 mg/dL (sensitivity, 39%; AUC = 0.82) and pH <= 7.20 (sensitivity, 41%; AUC = 0.78), for identifying the need for drainage. The combined sensitivity of pleural fluid TNF-{alpha} and LDH was found to be 91%.

Conclusions: Pleural TNF-{alpha} may contribute to the identification of patients with nonpurulent CPPE with at least the same diagnostic accuracy, if not better, than the use of pH, glucose, or LDH.

Key Words: empyema • parapneumonic effusion • tumor necrosis factor • pH • pleural effusion




This article has been cited by other articles:


Home page
ChestHome page
G. E. Utine, U. Ozcelik, E. Yalcin, D. Dogru, N. Kiper, A. Aslan, and G. Kanra
Childhood Parapneumonic Effusions: Biochemical and Inflammatory Markers
Chest, September 1, 2005; 128(3): 1436 - 1441.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Odeh, A. Oliven, J. M. Porcel, M. Vives, and A. Esquerda
Tumor Necrosis Factor-{alpha} in Parapneumonic Effusion
Chest, May 1, 2005; 127(5): 1868 - 1869.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.